Arcutis Biotherapeutics, Inc. (ARQT)
23.97
-0.15
(-0.62%)
USD |
NASDAQ |
Mar 05, 16:00
23.96
-0.01
(-0.04%)
After-Hours: 20:00
Arcutis Biotherapeutics Cash from Investing (Quarterly) : -34.18M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CorMedix, Inc. | -291.32M |
| ADMA Biologics, Inc. | -0.276M |
| ANI Pharmaceuticals, Inc. | -1.403M |
| Amicus Therapeutics, Inc. | -6.494M |
| Mirum Pharmaceuticals, Inc. | 1.006M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 26.18M |
| Cash from Financing (Quarterly) | 3.722M |
| Free Cash Flow | -16.31M |
| Free Cash Flow Per Share (Quarterly) | 0.1931 |
| Free Cash Flow to Equity (Quarterly) | 25.73M |
| Free Cash Flow to Firm (Quarterly) | 29.11M |
| Free Cash Flow Yield | -0.52% |